Mechanisms of epileptogenicity in focal malformations caused by abnormal cortical development

Neurosurgery Clinics of North America

Volumn 13, Issue 1, 2002, Pages 27-33

  Ying, Zhong ^a   Najm, Imad M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IONOTROPIC RECEPTOR;

BRAIN MALFORMATION; CORTICAL DYSPLASIA; DISEASE ASSOCIATION; EPILEPSY; EPILEPTOGENESIS; GABAERGIC SYSTEM; GENETIC SCREENING; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0036148618     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3680(02)80004-3     Document Type: Article

References (80)

1. Die gruppierung der epilepsie
2. Glutamate AMPA receptors in the fascia dentata of human and rat hippocampal epilepsy
3. Parvalbumin in most gamma-aminobutyric acid containing neurons of the rat cerebral cortex
4. Horizontal spread of synchronized activity in neocortex and its control by GABA-mediated inhibition
5. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus
6. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia
7. Reduction of zolpidem sensitivity in a freeze lesion model of neocortical dysgenesis
8. Alterations in NMDA receptors in a rat model of cortical dysplasia
9. The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs
10. Heterogeneity of GABAergic cells in cat visual cortex
11. Neuropathologic finding in surgically treated hemimegalencephaly: Immunohistochemical, morphometric, and ultrastructural study
12. Lifethreatening focal status epilepticus due to occult cortical dysplasia
13. Experimentally induced focal microgyria and status verrucosus deformis in rats - Pathogenesis and interrelation. Histological and autoradiographical study
14. Surgery for seizures
15. Neuropathologic finding in cortical resections (including hemispherectomies) performed to the treatment of intractable childhood epilepsy
16. Parvalbumin and calbindin-D 28 immunocytochemistry in human neocortical epileptic foci
17. Abnormal localcircuit neurons in epilepsia partialis continua associated with focal cortical dysplasia
18. Localized cortical dysgenesis and epilepsy
19. Dysplasias of cerebral cortex
20. Taylor's cortical dysplasia: A confocal and ultrastructural immunohistochemical study
21. Malformations of the nervous system
22. Two classes of cortical GABA neurons defined by differential calcium-binding protein immunoreactivities
23. Focal cortical dysplasia in children
24. Surgical treatment of epilepsy due to cortical dysplasia: Clinical and EEG findings
25. Zinc potentiates agonist-induced currents at certain splice variants of NMDA receptor
26. Time course of the reduction of GABA terminals in a model of focal epilepsy: A glutamic acid decarboxylase immunocytochemical study
27. Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel
28. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits
29. Cortical dysplasia in surgical specimens
30. Cerebral cortical dysplasia: Giant neurons show potential for increased excitation and axonal plasticity
31. Common forms of synaptic plasticity in the hippocampus and neo-cortex in vitro
32. GABAergic neurons containing the calcium binding protein parvalbumin in the rat hippocampus and dentate gyrus
33. Molecular diversity of the NMDA receptor channel
34. MRI in focal cortical dysplasia
35. Distribution of AMPA receptor subunits in the hippocampal formation of temporal lobe epilepsy patients
36. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons
37. A receptor channels
38. NMDA-receptor dependent synaptic plasticity: Multiple forms and mechanisms
39. Inhibitory neurons in the human epileptogenic temporal neocortex
40. Developmental neuropathology and impact of perinatal brain damage III: Gray matter lesions of the neocortex
41. Hippocampal AMPA and NMDA mRNA levels and subunit immunoreactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy
42. Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in temporal lobe epilepsy patients
43. Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia
44. Permeation and block of N-methyl-S-aspartic acid receptors channels by divalent cations in mouse cultured neurons
45. Excitatory amino acids in epilepsy and potential novel therapies
46. NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia
47. Inhibitory control of local excitatory synaptic circuits in the guinea pig hippocampus
48. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system
49. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
50. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
51. Molecular cloning and characterization of the rat NMDA receptor
52. B receptors
53. Epileptogenicity correlated with increased N-Methyl-D-Aspartate receptor subunit NR2A/B in human focal cortical dysplasia
54. Molecular diversity of glutamate receptors and implications for brain function
55. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system
56. B receptors
57. GABA and epileptogenesis
58. Focal neuronal migration disorders and intractable partial epilepsy: Results of surgical treatment
59. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results
60. Control mechanism in cortical epileptogenic foci. "Surround" inhibition
61. Beitrage zur kenntnis der normalen und pathologischen hirnrindenbildung
62. Axon terminals of GABAergic chandelier cells are lost at the epileptic foci
63. Neuropathology of hemimegalencephaly
64. Reduced density of parvalbumin- and calbindin D28k-immunoreactive neurons in experimental cortical dysplasia
65. Local circuit considerations and intrinsic neuronal properties involved in hyperexcitability and cell synchronization
66. Cortical dysplasia: An immunocytochemcal study of three patients
67. Inhibitory circuits in human dysplasia tissue
68. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing
69. A glimpse into abnormal cortical development and epileptogenesis at epilepsy surgery
70. Focal dysplasia of the cerebral cortex in epilepsy
71. Calcium-binding proteins as markers for subpopulations of GABAergic neurons in monkey striate cortex
72. The neuropathology to human symptomatic epilepsy
73. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists
74. Seizure outcome after epilepsy surgery in children and adolescents
75. Selective coexpression of NMDAR2/B and NMDAR 1 subunit proteins in dysplastic neurons of human epileptic cortex
76. Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex
77. Increased densities of AMPA GluR 1 subunit proteins and presynaptic mossy fiber sprouting in the fascia dentata of human hippocampal epilepsy
78. Hippocampal chemical anatomy in pediatric and adolescent patients with hippocampal or extrahippocampal epilepsy
79. Reduced inhibition in an animal model of cortical dysplasia
80. B receptors